BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
2 hedge funds and large institutions have $19.8K invested in BIMI International Medical Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.
67% less funds holding
Funds holding: 6 → 2 (-4)
97% less capital invested
Capital invested by funds: $649K → $19.8K (-$629K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$206K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$193K |
| 3 |
Jane Street
New York
|
-$141K |
| 4 |
Millennium Management
New York
|
-$73K |
| 5 |
Morgan Stanley
New York
|
-$39.2K |
BIMI Hedge Fund Activity: Q3 2018 in Review
2 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q3 2018, worth a combined $19.8K — down 97% from $649K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BIMI and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Renaissance Technologies, exiting entirely with an estimated $206K sold.
- 2 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q3 2018, down from 6 in Q2 2018.
- Funds reported $19.8K of BIMI International Medical Inc. Common Stock stock for Q3 2018, down 97% quarter-over-quarter.
- 0 funds opened new BIMI International Medical Inc. Common Stock positions in Q3 2018 and 4 closed out, a net change of -4 holders.
- The largest BIMI International Medical Inc. Common Stock seller in Q3 2018 was Renaissance Technologies, an estimated $206K sold.
Based on aggregated 13F filings for Q3 2018.